IGI
This article was originally published in The Rose Sheet
Executive Summary
Seeking new distributor for its dermatological products, including the Wellskin skin care line, following Glaxo Wellcome's decision to exit the U.S. physician-dispensed skin care market to focus resources on its core prescription business, IGI announced. The company said it is "seeking strategic partners for whom skin care is a product growth area" to facilitate a "smooth transition." Wellskin, introduced in 1996 under the brand name Nova Skin, was renamed in 1997 while marketed by Glaxo under an agreement with IGI ("The Rose Sheet" Dec. 1, 1997, p. 10)